Loading...
Perforation of small intestinal metastasis of lung adenocarcinoma treated with pembrolizumab: a case report
BACKGROUND: Pembrolizumab is an immune checkpoint inhibitor and is an anti-human programmed cell death-1 (PD-1) monoclonal antibody. Pembrolizumab is used for non-small cell lung carcinoma with high programmed cell death ligand-1 (PD-L1) expression. It has been found that better overall survival can...
Na minha lista:
| Udgivet i: | Surg Case Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6821905/ https://ncbi.nlm.nih.gov/pubmed/31667679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-019-0730-6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|